Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-10 3:47 pm Sale | 2025-12-09 | 13G | Enveric Biosciences, Inc. ENVB | Braeden Lichti | 0 0.000% | -29,920 (Position Closed) | Filing History |
| 2025-12-05 7:06 pm Purchase | 2025-12-03 | 13G | Enveric Biosciences, Inc. ENVB | Braeden Lichti | 29,920 5.010% | 29,920 (New Position) | Filing History |
| 2025-03-28 9:47 pm Purchase | 2025-03-26 | 13D | PMGC Holdings Inc. ELAB | Braeden Lichti | 953,268 52.350% | 953,268 (New Position) | Filing History |
| 2025-03-28 9:46 pm Purchase | 2024-09-24 | 13D | PMGC Holdings Inc. ELAB | Braeden Lichti | 781 0.190% | 781 (New Position) | Filing History |
| 2024-02-21 10:57 am Purchase | 2023-11-13 | 13D | PMGC Holdings Inc. ELAB | Braeden Lichti | 780 22.070% | 780 (New Position) | Filing History |
| 2023-07-12 4:26 pm Purchase | 2023-04-18 | 13G | Marizyme, Inc. MRZM | Braeden Lichti | 9,786,874 17.890% | 9,786,874 (New Position) | Filing History |